Johnson & Johnson Vaccine Breaks All COVID Barriers

FDA approves Johnson & Johnson COVID vaccine after a wide range of safety and efficacy results.
The single dose vaccine has been found to 66% effective.
It has a 64% efficacy on new variants like the South African Strain.
The vaccine prevents asymptomatic infection in 4 Weeks.
It’s 74% effective in reducing asymptomatic infection.
The vaccine shows no major side effects in all types of people, irrespective of age, race, ethnicity, comorbidity or covid infection.
It has a higher safety...